| The Vicious Cycle Between α‐Synuclein Aggregation and Autophagic‐Lysosomal Dysfunction G Bellomo, S Paciotti, L Gatticchi, L Parnetti Movement Disorders 35 (1), 34-44, 2020 | 93 | 2020 |
| Are we ready for detecting α-synuclein prone to aggregation in patients? The case of “protein-misfolding cyclic amplification” and “real-time quaking-induced conversion” as … S Paciotti, G Bellomo, L Gatticchi, L Parnetti Frontiers in neurology 9, 415, 2018 | 84 | 2018 |
| Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid J Gobom, L Parnetti, P Rosa-Neto, M Vyhnalek, S Gauthier, S Cataldi, ... Clinical Chemistry and Laboratory Medicine (CCLM) 60 (2), 207-219, 2022 | 64 | 2022 |
| CSF and blood biomarkers in neuroinflammatory and neurodegenerative diseases: implications for treatment L Gaetani, FP Paoletti, G Bellomo, A Mancini, S Simoni, M Di Filippo, ... Trends in pharmacological sciences 41 (12), 1023-1037, 2020 | 60 | 2020 |
| α-Synuclein seed amplification assays for diagnosing synucleinopathies: the way forward G Bellomo, CMG De Luca, FP Paoletti, L Gaetani, F Moda, L Parnetti Neurology 99 (5), 195-205, 2022 | 56 | 2022 |
| Parkinson's and Lewy body dementia CSF biomarkers L Parnetti, S Paciotti, L Farotti, G Bellomo, FN Sepe, P Eusebi Clinica Chimica Acta 495, 318-325, 2019 | 52 | 2019 |
| Neuroinflammation and Alzheimer’s disease: a machine learning approach to CSF proteomics L Gaetani, G Bellomo, L Parnetti, K Blennow, H Zetterberg, M Di Filippo Cells 10 (8), 1930, 2021 | 45 | 2021 |
| Alpha and beta synucleins: from pathophysiology to clinical application as biomarkers L Barba, F Paolini Paoletti, G Bellomo, L Gaetani, S Halbgebauer, P Oeckl, ... Movement disorders 37 (4), 669-683, 2022 | 44 | 2022 |
| An unbalanced synaptic transmission: cause or consequence of the amyloid oligomers neurotoxicity? M Sciaccaluga, A Megaro, G Bellomo, G Ruffolo, M Romoli, E Palma, ... International Journal of Molecular Sciences 22 (11), 5991, 2021 | 38 | 2021 |
| Aggregation kinetics of the Aβ1–40 peptide monitored by NMR G Bellomo, S Bologna, L Gonnelli, E Ravera, M Fragai, M Lelli, C Luchinat Chemical communications 54 (55), 7601-7604, 2018 | 38 | 2018 |
| Clinical reporting following the quantification of cerebrospinal fluid biomarkers in Alzheimer's disease: An international overview C Delaby, CE Teunissen, K Blennow, D Alcolea, I Arisi, EB Amar, ... Alzheimer's & Dementia 18 (10), 1868-1879, 2022 | 34 | 2022 |
| Dissecting the interactions between human serum albumin and α-synuclein: New insights on the factors influencing α-synuclein aggregation in biological fluids G Bellomo, S Bologna, L Cerofolini, S Paciotti, L Gatticchi, E Ravera, ... The Journal of Physical Chemistry B 123 (20), 4380-4386, 2019 | 30 | 2019 |
| Machine learning driven profiling of cerebrospinal fluid core biomarkers in Alzheimer’s disease and other neurological disorders G Bellomo, A Indaco, D Chiasserini, E Maderna, F Paolini Paoletti, ... Frontiers in neuroscience 15, 647783, 2021 | 25 | 2021 |
| A/T/(N) profile in cerebrospinal fluid of Parkinson’s disease with/without cognitive impairment and dementia with lewy bodies G Bellomo, F Paolini Paoletti, E Chipi, M Petricciuolo, S Simoni, ... Diagnostics 10 (12), 1015, 2020 | 24 | 2020 |
| Multivariate curve resolution for 2D solid-state NMR spectra F Bruno, R Francischello, G Bellomo, L Gigli, A Flori, L Menichetti, ... Analytical chemistry 92 (6), 4451-4458, 2020 | 19 | 2020 |
| Cerebrospinal fluid lipoproteins inhibit α-synuclein aggregation by interacting with oligomeric species in seed amplification assays G Bellomo, S Paciotti, L Concha-Marambio, D Rizzo, AL Wojdaƚa, ... Molecular neurodegeneration 18 (1), 20, 2023 | 15 | 2023 |
| Cerebrospinal fluid β-synuclein as a synaptic biomarker for preclinical Alzheimer’s disease L Barba, SA Rumeileh, G Bellomo, FP Paoletti, S Halbgebauer, P Oeckl, ... Journal of Neurology, Neurosurgery & Psychiatry 94 (1), 83-86, 2023 | 13 | 2023 |
| Methods to discover and validate biofluid-based biomarkers in neurodegenerative dementias CE Teunissen, L Kimble, S Bayoumy, K Bolsewig, F Burtscher, ... Molecular & Cellular Proteomics 22 (10), 2023 | 12 | 2023 |
| A combination of neurofilament light, glial fibrillary acidic protein, and neuronal pentraxin-2 discriminates between frontotemporal dementia and other dementias K Bolsewig, YS Hok-A-Hin, FN Sepe, L Boonkamp, D Jacobs, G Bellomo, ... Journal of Alzheimer's Disease 90 (1), 363-380, 2022 | 11 | 2022 |
| MR spectroscopy in prostate cancer: new algorithms to optimize metabolite quantification G Bellomo, F Marcocci, D Bianchini, E Mezzenga, V D’Errico, E Menghi, ... PLoS One 11 (11), e0165730, 2016 | 11 | 2016 |
Davide ChiasseriniUniversity of Perugia, Perugia, Italy在 unipg.it 的电子邮件经过验证
